학술논문
From natalizumab to fingolimod in eight weeks — Immunological, clinical, and radiological data in quest of the optimal switch
Document Type
Article
Author
Source
In Clinical Immunology March 2017 176:87-93
Subject
Language
ISSN
1521-6616